This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Xention Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Fiona Chan - Innovator in Potassium Channel Inhibitors
Introduction
Fiona Chan is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of potassium channel inhibitors. Her innovative work has the potential to impact various therapeutic areas.
Latest Patents
Fiona Chan holds a patent for her invention titled "Thieno-pyrimidines, useful as potassium channel inhibitors." This patent includes compounds of formula (I), which are designed to inhibit potassium channels. The invention also encompasses pharmaceutical compositions that utilize these compounds for therapeutic purposes, specifically targeting diseases mediated by K3.1 and/or K3.4 channels.
Career Highlights
Fiona has been instrumental in advancing research at Xention Limited, where she applies her expertise in medicinal chemistry. Her work focuses on developing novel compounds that can lead to effective treatments for various medical conditions.
Collaborations
Fiona collaborates with notable colleagues, including Derek Edward John and Simon David Edwards, who contribute to her research efforts and enhance the innovative environment at Xention Limited.
Conclusion
Fiona Chan's contributions to the field of potassium channel inhibitors exemplify her commitment to advancing medical science. Her innovative spirit and collaborative approach continue to drive progress in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile